COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
Product updates
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Infermedica 2018: Year in Review
With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.
We’ve moved Symptomate to the next level
Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.
Infermedica 2017: Year in review
Over three million diagnostic interviews conducted with patients. Amongst other changes at Infermedica in 2017.
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Infermedica 2018: Year in Review
With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.
We’ve moved Symptomate to the next level
Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.
Infermedica 2017: Year in review
Over three million diagnostic interviews conducted with patients. Amongst other changes at Infermedica in 2017.